Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 469

1.

[Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M.

Bull Cancer. 2008 Jan;95(1):141-5. doi: 10.1684/bdc.2008.0553. Review. French.

2.

[Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].

Kavanagh M, Ouellet JF; Comité de l'Evolution des Pratiques en Oncologie..

Bull Cancer. 2006 Sep;93(9):867-74. Review. French.

3.

[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].

Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M.

Minerva Chir. 2002 Oct;57(5):597-605. Review. Italian.

PMID:
12370661
4.

[Updated treatment of peritoneal carcinomas: a review].

Deraco M, Laterza B, Kusamura S, Baratti D.

Minerva Chir. 2007 Dec;62(6):459-76. Review. Italian.

PMID:
18091656
5.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
7.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.

Nesher E, Greenberg R, Avital S, Skornick Y, Schneebaum S.

Isr Med Assoc J. 2007 Nov;9(11):787-90.

8.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
9.

[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].

Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.

Ann Ital Chir. 2008 Jul-Aug;79(4):231-9. Italian.

PMID:
19093624
10.

Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.

Asero S, Caruso M, Vallone N, Luciani AG, Lombardo V, Terranova G, Ettore G, Giannone G.

In Vivo. 2009 Jul-Aug;23(4):645-7.

11.

[Intraperitoneal hyperthermic chemotherapy in the management of recurrent peritoneal carcinomatosis. Preliminary results in 5 patients].

Lubrano J, Huet E, Foulatier O, Michel P, Michot F, Ténière P, Scotté M.

Gastroenterol Clin Biol. 2006 Nov;30(11):1297-300. French.

12.

Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program.

Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, Lok I, Morris DL.

Ann Surg. 2010 Feb;251(2):323-9. doi: 10.1097/SLA.0b013e3181c9b53c.

PMID:
20040853
13.

[Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].

Roviello F, Caruso S, Marrelli D, Pedrazzani C, Neri A, De Stefano A, Pinto E.

G Chir. 2011 Apr;32(4):211-33. Review. Italian.

PMID:
21554854
14.

Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.

Mohamed F, Moran BJ.

Cancer J. 2009 May-Jun;15(3):196-9. doi: 10.1097/PPO.0b013e3181a58d56. Review.

PMID:
19556904
15.

Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.

Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi RA Jr, Vaglini M.

Tumori. 2002 Sep-Oct;88(5):370-5.

PMID:
12487553
16.

[Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].

Königsrainer I, Beckert S, Brücher B, Zieker D, Königsrainer A.

Dtsch Med Wochenschr. 2011 Sep;136(36):1811-4. doi: 10.1055/s-0031-1286108. Epub 2011 Aug 31. German.

PMID:
21882140
17.

Clinical results of cytoreduction and HIPEC in pseudomyxoma peritonei.

Lutton NJ, Moran BJ.

Cancer Treat Res. 2007;134:319-28. Review. No abstract available.

PMID:
17633063
18.

Peritoneal-based malignancies and their treatment.

Teo M.

Ann Acad Med Singapore. 2010 Jan;39(1):54-7. Review.

19.

Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Iversen LH, Rasmussen PC, Laurberg S.

Br J Surg. 2013 Jan;100(2):285-92. doi: 10.1002/bjs.8908. Epub 2012 Nov 2.

PMID:
23124619
20.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976

Supplemental Content

Support Center